Global Liquid Biopsy Products Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA. This report mainly covers the Liquid Biopsy Products product type by technology（circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type(blood, urine and other bio fluids (Tissue fluids and Saliva) based), while we can also offer any product survey report related to the Liquid Biopsy Products industry chain.

Published by: GIR (GlobalInfoResearch)

Catalog: Healthcare

Publishing Date: Sep 2016

Single User License: USD 3480

Corporate Users License: USD 4680

Delivery time: 24 hours

Pages: 114

Tables and Figures: 135

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=769[url]

Scope of the Report:

This report focuses on the Liquid Biopsy Products in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

RainDanceTechnologies

Biocartis

Qiagen

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Silicon Biosystems

Adaptive Biotechnologies

Biocept

Angle plc

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle and Africa

Market Segment by Type, covers

Blood Sample based

Urine Sample based

Other Bio Fluids based

Market Segment by Applications, can be divided into

Application 1

Application 2

Application 3

There are 13 Chapters to deeply display the global Liquid Biopsy Products market.

Chapter 1, to...